Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Gender based differences in drug eluting stent implantation - data from the German ALKK registry suggest underuse of DES in elderly women.

Russ MA, Wackerl C, Zeymer U, Hochadel M, Kerber S, Zahn R, Zrenner B, Topp H, Schächinger V, Weber MA; ALKK-Study Group..

BMC Cardiovasc Disord. 2017 Feb 27;17(1):68. doi: 10.1186/s12872-017-0500-y.

2.

Percutaneous Coronary Intervention: Safety of Methotrexate and Its Possible Benefits on Restenosis After Bare-Metal Stent Deployment.

Gouveia V, Oliveira DC, Tenorio E, Brito N, Sarinho E.

Cardiol Res. 2016 Jun;7(3):104-109. doi: 10.14740/cr468w. Epub 2016 Jun 24.

3.
4.

The stenting strategy of drug-eluting stents for coronary artery disease in patients on dialysis.

Fujita H, Nasu K, Terashima M, Ito T, Tani T, Suzuki T, Ohte N.

SAGE Open Med. 2014 Dec 16;2:2050312114562395. doi: 10.1177/2050312114562395. eCollection 2014 Dec 16.

5.

Attending to links in the safety chain for drug-eluting stents.

Fitzgerald PJ, Leon MB.

Neth Heart J. 2006 Sep;14(9):285-286. No abstract available.

6.

Prevention of stent thrombosis: challenges and solutions.

Reejhsinghani R, Lotfi AS.

Vasc Health Risk Manag. 2015 Jan 27;11:93-106. doi: 10.2147/VHRM.S43357. eCollection 2015 Jan 27. Review.

7.

Comparison of full lesion coverage versus spot drug-eluting stent implantation for coronary artery stenoses.

Kim S, Yun KH, Kang WC, Shin DH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Hong MK.

Yonsei Med J. 2014 May;55(3):584-91. doi: 10.3349/ymj.2014.55.3.584. Epub 2014 Apr 1.

8.

Potassium concentration on admission is an independent risk factor for target lesion revascularization in acute myocardial infarction.

Honda T, Fujimoto K, Miyao Y, Koga H, Ishii M.

ScientificWorldJournal. 2014 Jan 12;2014:946803. doi: 10.1155/2014/946803. eCollection 2014 Jan 12.

9.

One-year clinical outcomes of BioMatrix™-Biolimus A9™ eluting stent: the e-BioMatrix multicenter post marketing surveillance registry in India.

Mehta AB, Chandra P, Dalal J, Shetty P, Desai D, Chocklingam K, Prajapati J, Kumar P, Magarkar V, Vasawada A, Goyal BK, Kumar V, Rao VS, Babu R, Parikh P, Kaul U, Patil A, Mhetre T, Rangnekar H.

Indian Heart J. 2013 Sep-Oct;65(5):593-9. doi: 10.1016/j.ihj.2013.08.031. Epub 2013 Sep 23.

10.

Clinical outcomes with Biolimus (A9)™ eluting stent, 'BioMatrix' in diabetic patients--interim results from multicenter post market surveillance registry in India.

Seth A, Hiremath S, Dani S, Kapoor S, Jain RK, Abhaichand R, Trivedi S, Kaul U, Patil A, Khemnar B, Rangnekar H.

Indian Heart J. 2013 Sep-Oct;65(5):586-92. doi: 10.1016/j.ihj.2013.08.030. Epub 2013 Sep 21.

11.

Miniaturized self-expanding drug-eluting stent in small coronary arteries: late effectiveness.

Oliveira FR, Mattos LA, Abizaid A, Abizaid AS, Costa JR, Costa R, Staico R, Botelho R, Sousa JE, Sousa A.

Arq Bras Cardiol. 2013 Nov;101(5):379-87. doi: 10.5935/abc.20130199. Epub 2013 Oct 8. English, Portuguese.

12.

Perioperative management of antiplatelet therapy in patients with drug-eluting stents.

Dimitrova G, Tulman DB, Bergese SD.

HSR Proc Intensive Care Cardiovasc Anesth. 2012;4(3):153-67.

13.

One-year clinical outcomes of ultra long apollo polymer-based Paclitaxel-eluting stents in patients with complex, long coronary artery lesions.

Salarifar M, Kassaian SE, Alidoosti M, Haji-Zeinali AM, Poorhoseini HR, Nematipour E, Amirzadegan A, Saroukhani S.

J Tehran Heart Cent. 2011 Summer;6(3):138-42. Epub 2011 Aug 31.

14.

Comparison of bare-metal and drug-eluting stents in patients with chronic kidney disease (from the NHLBI Dynamic Registry).

Green SM, Selzer F, Mulukutla SR, Tadajweski EJ, Green JA, Wilensky RL, Laskey WK, Cohen HA, Rao SV, Weisbord SD, Lee JS, Reis SE, Kip KE, Kelsey SF, Williams DO, Marroquin OC.

Am J Cardiol. 2011 Dec 1;108(11):1658-64. doi: 10.1016/j.amjcard.2011.07.029. Epub 2011 Sep 3.

15.
16.

Outcomes of small coronary artery stenting with bare-metal stents versus drug-eluting stents: results from the NHLBI Dynamic Registry.

Parikh SV, Luna M, Selzer F, Marroquin OC, Mulukutla SR, Abbott JD, Holper EM.

Catheter Cardiovasc Interv. 2014 Feb;83(2):192-200. doi: 10.1002/ccd.23194. Epub 2013 Oct 24.

17.

The disutility of restenosis--the impact of repeat percutaneous coronary intervention on quality of life.

Ploegmakers MM, Viscaal AM, Finch L, Mayo NE, Brophy JM.

Can J Cardiol. 2010 Jun-Jul;26(6):197-200.

18.

The significance of clopidogrel low-responsiveness on stent thrombosis and cardiac death assessed by the verifynow p(2)y(12) assay in patients with acute coronary syndrome within 6 months after drug-eluting stent implantation.

Lee K, Lee SW, Lee JW, Kim SY, Youn YJ, Ahn MS, Kim JY, Yoo BS, Yoon J, Choe KH.

Korean Circ J. 2009 Dec;39(12):512-8. doi: 10.4070/kcj.2009.39.12.512. Epub 2009 Dec 30.

19.
20.

Efficacies of the new paclitaxel-eluting Coroflex Please stent in percutaneous coronary intervention; comparison of efficacy between Coroflex Please and Taxus (ECO-PLEASANT) trial: study rationale and design.

Seo JB, Jeon HK, Park KW, Park JS, Bae JH, Kim SW, Moon KW, Choi JW, Lee SG, Chung WY, Youn TJ, Kim SJ, Kim DI, Kim BO, Hyon MS, Park KS, Cha TJ, Hwang HK, Hur SH, Kim HS.

Trials. 2009 Oct 23;10:98. doi: 10.1186/1745-6215-10-98.

Supplemental Content

Support Center